Download our scientific poster on generating monoclonal production cell lines with > 99.9% probability.
Download our scientific poster, presented at BPI Europe 2017 on improved clone evaluation using ambr® 15 mini bioreactor system.
View the latest scientific poster from Cellca.
Following the news release from Alligator Bioscience on 12th June 2017, Sartorius Stedim Cellca GmbH is delighted to partner with the innovative Swedish biotech company, Alligator Bioscience to support the pre-clinical development of their 4-1BB immuno-oncology antibody ATOR-1017. ATOR-1017 is an agonistic antibody that activates the co-stimulatory receptor 4-1BB (also known as CD137) expressed on More
Download our latest scientific poster presented at ESACT 2017, on signal peptide evaluation during cell line development.
Download our slides to find out more about our cell line development services and the Cellca CHO Expression Platform.
View our flyer to find out more about our full range of physicochemical and structural testing services.
Goettingen, GER | Glasgow, UK – May 4, 2017: Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry, announced the launch of a full range of chemistry testing services. Offered by its subsidiary BioOutsource, they characterize the physicochemical properties and structural attributes of therapeutic monoclonal antibodies (mAbs). The service platform methods have More
On Wednesday 19th April 2017, Sartorius Stedim BioOutsource was named as Scottish Life Sciences Company of the Year at the Made in Scotland awards. The annual Made in Scotland awards rewards Scottish companies that have innovative products and services and have subsequently found success domestically and internationally. We were delighted to be announced as the winner More
A Quality by Design approach to de-risk biosimilar development Learn more about the evolving biosimilar development pathway and how a QbD approach ensures a step-wise, orthogonal process to de-risk development and improve speed to market. Watch on demand now